A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Cronos Group Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 30,102 shares of CRON stock, worth $58,096. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,102
Previous 30,940 2.71%
Holding current value
$58,096
Previous $72,000 8.33%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$2.08 - $2.49 $1,743 - $2,086
-838 Reduced 2.71%
30,102 $66,000
Q2 2024

Jul 26, 2024

SELL
$2.27 - $3.02 $3,484 - $4,635
-1,535 Reduced 4.73%
30,940 $72,000
Q1 2024

Apr 24, 2024

SELL
$1.93 - $2.7 $8,677 - $12,139
-4,496 Reduced 12.16%
32,475 $85,000
Q4 2023

Feb 09, 2024

SELL
$1.72 - $2.19 $4,169 - $5,308
-2,424 Reduced 6.15%
36,971 $77,000
Q3 2023

Oct 24, 2023

BUY
$1.68 - $2.47 $1,374 - $2,020
818 Added 2.12%
39,395 $79,000
Q2 2023

Jul 13, 2023

SELL
$1.67 - $2.04 $20,833 - $25,449
-12,475 Reduced 24.44%
38,577 $76,000
Q1 2023

May 11, 2023

SELL
$1.87 - $2.6 $7,294 - $10,142
-3,901 Reduced 7.1%
51,052 $99,000
Q4 2022

Feb 08, 2023

SELL
$2.49 - $3.5 $16,742 - $23,534
-6,724 Reduced 10.9%
54,953 $140,000
Q3 2022

Oct 17, 2022

SELL
$2.82 - $3.58 $13,129 - $16,668
-4,656 Reduced 7.02%
61,677 $173,000
Q2 2022

Jul 13, 2022

SELL
$2.59 - $3.92 $10,396 - $15,734
-4,014 Reduced 5.71%
66,333 $187,000
Q1 2022

May 12, 2022

SELL
$3.0 - $4.25 $9,126 - $12,928
-3,042 Reduced 4.15%
70,347 $273,000
Q4 2021

Feb 03, 2022

SELL
$3.85 - $6.71 $29,933 - $52,170
-7,775 Reduced 9.58%
73,389 $287,000
Q3 2021

Nov 02, 2021

BUY
$5.6 - $8.58 $18,155 - $27,816
3,242 Added 4.16%
81,164 $459,000
Q2 2021

Aug 10, 2021

SELL
$7.16 - $9.41 $9,995 - $13,136
-1,396 Reduced 1.76%
77,922 $670,000
Q1 2021

May 07, 2021

BUY
$7.52 - $15.55 $61,739 - $127,665
8,210 Added 11.55%
79,318 $750,000
Q4 2020

Feb 04, 2021

SELL
$5.0 - $8.85 $1,855 - $3,283
-371 Reduced 0.52%
71,108 $493,000
Q3 2020

Oct 29, 2020

SELL
$4.96 - $7.08 $23,049 - $32,900
-4,647 Reduced 6.1%
71,479 $358,000
Q2 2020

Jul 27, 2020

BUY
$4.84 - $8.02 $15,241 - $25,254
3,149 Added 4.32%
76,126 $457,000
Q1 2020

May 08, 2020

SELL
$4.52 - $8.55 $297,768 - $563,256
-65,878 Reduced 47.44%
72,977 $413,000
Q4 2019

Feb 04, 2020

BUY
$6.14 - $9.3 $212,204 - $321,417
34,561 Added 33.14%
138,855 $1.07 Million
Q3 2019

Nov 06, 2019

SELL
$9.05 - $16.02 $169,289 - $299,670
-18,706 Reduced 15.21%
104,294 $943,000
Q3 2019

Oct 28, 2019

BUY
$9.05 - $16.02 $181 - $320
20 Added 0.02%
123,000 $1.11 Million
Q2 2019

Aug 15, 2019

BUY
$13.58 - $18.61 $16,200 - $22,201
1,193 Added 0.98%
122,980 $0
Q1 2019

May 08, 2019

BUY
$11.31 - $23.7 $776,997 - $1.63 Million
68,700 Added 129.41%
121,787 $0
Q4 2018

Feb 05, 2019

BUY
$6.8 - $12.88 $128,424 - $243,251
18,886 Added 55.22%
53,087 $551,000
Q3 2018

Nov 02, 2018

BUY
$5.65 - $13.75 $122,441 - $297,976
21,671 Added 172.95%
34,201 $0
Q2 2018

Aug 10, 2018

BUY
$5.52 - $7.93 $11,923 - $17,128
2,160 Added 20.83%
12,530 $0
Q1 2018

May 09, 2018

BUY
$5.51 - $10.97 $57,138 - $113,758
10,370 New
10,370 $0

Others Institutions Holding CRON

About Cronos Group Inc.


  • Ticker CRON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 377,896,000
  • Market Cap $729M
  • Description
  • Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of...
More about CRON
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.